UA106905U - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
UA106905U
UA106905U UAU201511330U UAU201511330U UA106905U UA 106905 U UA106905 U UA 106905U UA U201511330 U UAU201511330 U UA U201511330U UA U201511330 U UAU201511330 U UA U201511330U UA 106905 U UA106905 U UA 106905U
Authority
UA
Ukraine
Prior art keywords
pharmaceutical formulation
levocarnitine
injections
water
arginine hydrochloride
Prior art date
Application number
UAU201511330U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Mykola Ivanovych Humeniuk
Serhii Viktorovych Dontsov
Original Assignee
M T K Medical Center Ltd Liability Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M T K Medical Center Ltd Liability Company filed Critical M T K Medical Center Ltd Liability Company
Priority to UAU201511330U priority Critical patent/UA106905U/en
Publication of UA106905U publication Critical patent/UA106905U/en
Priority to MDA20180049A priority patent/MD4763C1/en
Priority to PCT/IB2016/056901 priority patent/WO2017085642A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The pharmaceutical formulation consists of arginine hydrochloride, levocarnitine and the water for injections.
UAU201511330U 2015-11-17 2015-11-17 Pharmaceutical formulation UA106905U (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
UAU201511330U UA106905U (en) 2015-11-17 2015-11-17 Pharmaceutical formulation
MDA20180049A MD4763C1 (en) 2015-11-17 2016-11-16 Pharmaceutical composition
PCT/IB2016/056901 WO2017085642A1 (en) 2015-11-17 2016-11-16 Pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201511330U UA106905U (en) 2015-11-17 2015-11-17 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
UA106905U true UA106905U (en) 2016-05-10

Family

ID=57142654

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201511330U UA106905U (en) 2015-11-17 2015-11-17 Pharmaceutical formulation

Country Status (1)

Country Link
UA (1) UA106905U (en)

Similar Documents

Publication Publication Date Title
IL276695B (en) Antibodies, pharmaceutical compositions and uses thereof
IL260852B (en) Methods, devices and systems for administering active substances through the lungs
CL2016002772A1 (en) Fast-acting insulin compositions
IL254124A0 (en) Novel 3-indol substituted derivatives, pharmaceutical compositions and methods for use
MY187540A (en) Compounds active towards bromodomains
MY191581A (en) Anti-pd-1 antibodies
EP3102188A4 (en) Novel disintegration systems for pharmaceutical dosage forms
HUE054551T2 (en) Orodispersible tablet containing estetrol
CL2015002897A1 (en) Bace1 inhibitors
EP3251708A4 (en) Medicinal fluid injector, and medicinal fluid supply apparatus having same
EA201791454A1 (en) DRUG FORMS FOR TRANSDERMAL ADMINISTRATION
MX2017000676A (en) ORITAVANCINA HIGH PURITY AND METHOD TO PRODUCE THE SAME.
IL252897A0 (en) Indenyl compounds, pharmaceutical compositions, and medical uses thereof
LT3236934T (en) Pharmaceutical composition, preparation and uses thereof
HUE056175T2 (en) Pharmaceutical compositions, preparation and uses thereof
PH12017500602A1 (en) Methods for treating ocular conditions
EP3256143A4 (en) Therapeutic compositions including mitochondrial fission inhibitor peptides, variants thereof and methods of using the same
EP3285758A4 (en) Co-crystal composition and its pharmaceutical use
IN2014CH00840A (en)
EP3190129A4 (en) Centrally-acting peptide derivative, and pharmaceutical composition
LT3229843T (en) Pharmaceutical composition, preparation and uses thereof
PH12017502148A1 (en) Pharmaceutical compositions and use thereof
GB2543709A (en) Pharmaceutical agent
UA106905U (en) Pharmaceutical formulation
AP2017009706A0 (en) Pharmaceutical compound comprising 13 glycerides, formulation and application thereof